SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivity

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants of concern (VOCs) exhibit escape from neutralizing antibodies, causing concern about vaccine effectiveness. However, while non-neutralizing cytotoxic functions of antibodies are associated with improved disease outcome and vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales: Richardson, Simone I., Manamela, Nelia P., Motsoeneng, Boitumelo M., Kaldine, Haajira, Ayres, Frances, Makhado, Zanele, Mennen, Mathilda, Skelem, Sango, Williams, Noleen, Sullivan, Nancy J., Misasi, John, Gray, Glenda G., Bekker, Linda-Gail, Ueckermann, Veronica, Rossouw, Theresa M., Boswell, Michael T., Ntusi, Ntobeko A.B., Burgers, Wendy A., Moore, Penny L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761540/
https://www.ncbi.nlm.nih.gov/pubmed/35233544
http://dx.doi.org/10.1016/j.xcrm.2022.100510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761540/
https://www.ncbi.nlm.nih.gov/pubmed/35233544
http://dx.doi.org/10.1016/j.xcrm.2022.100510

Ejemplares similares